A detailed history of Xr Securities LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Xr Securities LLC holds 285 shares of LLY stock, worth $257,272. This represents 0.05% of its overall portfolio holdings.

Number of Shares
285
Previous 1,353 78.94%
Holding current value
$257,272
Previous $1.05 Million 75.48%
% of portfolio
0.05%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $774,161 - $970,854
-1,068 Reduced 78.94%
285 $258,000
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $531,203 - $710,675
897 Added 196.71%
1,353 $1.05 Million
Q4 2023

Feb 02, 2024

BUY
$525.19 - $619.13 $239,486 - $282,323
456 New
456 $265,000
Q1 2023

May 02, 2023

BUY
$310.63 - $364.82 $2.11 Million - $2.48 Million
6,790 Added 594.57%
7,932 $2.72 Million
Q4 2022

Jan 03, 2023

SELL
$321.55 - $374.67 $995,518 - $1.16 Million
-3,096 Reduced 73.05%
1,142 $418,000
Q3 2022

Oct 18, 2022

BUY
$296.48 - $337.87 $1.26 Million - $1.43 Million
4,238 New
4,238 $1.37 Million
Q2 2022

Jul 14, 2022

SELL
$278.73 - $327.27 $427,014 - $501,377
-1,532 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$234.69 - $291.66 $265,669 - $330,159
-1,132 Reduced 42.49%
1,532 $439,000
Q4 2020

Jan 13, 2021

BUY
$130.46 - $172.63 $160,074 - $211,817
1,227 Added 85.39%
2,664 $450,000
Q3 2020

Oct 28, 2020

BUY
$146.22 - $169.13 $210,118 - $243,039
1,437 New
1,437 $213,000
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $291,665 - $351,016
-2,138 Closed
0 $0
Q1 2020

Apr 09, 2020

BUY
$119.05 - $147.35 $254,528 - $315,034
2,138 New
2,138 $297,000
Q2 2019

Jul 10, 2019

SELL
$110.79 - $129.32 $1.05 Million - $1.23 Million
-9,499 Closed
0 $0
Q1 2019

Apr 08, 2019

BUY
$111.31 - $131.02 $771,378 - $907,968
6,930 Added 269.75%
9,499 $1.23 Million
Q4 2018

Jan 03, 2019

BUY
$105.9 - $118.64 $272,057 - $304,786
2,569 New
2,569 $297,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.